Bioneer Corporation (064550.KQ) KOE

11,910.00

-140(-1.16%)

Updated at January 15 10:27AM

Currency In KRW

Bioneer Corporation

Address

8-11, Munpyeongseo-ro

Daejeon,

Korea, Republic of

Phone

82 1 588 9788

Sector

Healthcare

Industry

Biotechnology

Employees

608

First IPO Date

December 29, 2005

Key Executives

NameTitlePayYear Born
Han-Oh ParkFounder, Chief Executive Officer & Chairman01962
Geun-Bok SeoExecutive Officer0N/A
Sang-Chul KimExecutive Officer01953
Tai-Hyung ParkExecutive Officer01957
Pil-Ho LeeExecutive Officer0N/A
Seung-Wook HamExecutive Officer0N/A
Young-Cheol ChoiExecutive Officer0N/A
Jae-Hyung YuHead of Sales Division and Director01967
Jin-Pyeong JeongDirector and Head of Management Support Division01963
Jae-Ha KimDirector and Director of Nano Bio Bus. Division01962

Description

Bioneer Corporation engages in the biotechnology research products, molecular diagnosis, drugs, and probiotics businesses in South Korea. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide functional analysis, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, electrophoresis, spectrophotometer, and microbial culture. It also provides molecular diagnosis, including MDx technologies, human diagnostics kits, MDx extraction kits, and instruments; and products for animal diseases and nano-bio products. The company was founded in 1992 and is headquartered in Daejeon, South Korea.